Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator
Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Proposed Bill Would Allow FDA To Approve Drugs Without Clinical Trial Data May 1, 2015 Irvin Jackson Add Your CommentsNew legislation proposed by House Republicans may give pharmaceutical companies even greater ability to introduce new products without thorough testing, giving the FDA permission to approve medications based on scientific data considered much weaker than what it currently uses.ย The FDA is already under fire for failing to often require more stringent premarket studies for several drugs and medical devices that turned out to carry dangerous side effects or defects after they were on the market. Despite concerns about the latitude already provided to manufacturers, the new bill, known as the 21st Century Cures Act, would loosen the approval process even more by allowing the agency to approve drugs that have not had clinical trials.A legislative hearing was held yesterday by the House Energy and Commerce Subcommittee on Health. Republican committee members have put forth the bill as a way of updating how drugs are approved. In addition, the bill originally extended market exclusivity for certain kinds of drugs, meaning that pharmaceutical companies couldย sell them exclusively for longer before generic versions become available, but many if not all of those provisions appeared to have been removed by yesterday’s hearing.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe bill originally proposedย that instead of requiring randomized blinded clinical trials, the FDA could approve drugs using observational trials only. It also relaxed the need for clinical trials to approve new uses.Randomized, blinded clinical trials are considered the “gold standard” of medical research. It involves a group or groups of patients being given a particular medication while a control group is given a placebo that does nothing. Then those subjects are observed without doctors being aware of who was given the real drug or treatment until data is compiled. Specific endpoints are set, such as a reduction of specific symptoms, and adverse event trends are carefully monitored.Observational studies involve a control group and an unblinded subject group and draws inferences about the possible effects of treatments. They are considered unreliable for providing definitive evidence of safety, efficacy, or effectiveness.FDA officials defended its approval process at the hearing, and some of those provisions may be removed or softened in the most recent draft of the bill, which is half the size of its originaly 400 pages.The bill comes amid a push for drug companies to release clinical trial data following incidents of ghost-writing and study-tampering that has involved powerful drugs that were later approved by the FDA. Independent researchers warn that in some cases it appears the agency was outright lied to about adverse events and effectiveness of drugs in company-sponsored clinical trials.In February, a study found that the FDA was finding evidence of clinical trial fraud, but not reporting it in most cases.Supporters of the bill say more flexibility in the FDA approval requirements is necessary to speed up the process of getting vital drugs to patients in a timely manner.“While increasing accountability, this legislation would invest in the basic research so critical to equipping our nation’s best and brightest with the tools they need to discover the underpinnings of disease,” Subcommittee Chair Joseph R. Pitts said in a prepared statement. “[I]t would streamline the development of new therapies and technologies which has become increasingly challenging and resource intensive; and it would foster a dynamic, continuously learning health care delivery system.”“The 21st Century Cures (CC) draft is a reactionary assault on safety and science,” according to a summary of the bill by Public Citizen. “It would undermine the FDA, drive up health care costs, and harm patients and public health.”Public Citizen estimates that if the legislation is passed, nearly one in three drugs approved could be unsafe, ineffective, or both. The group also claims the bill would allow companies to make changes to medical devices without FDA oversight, allow companies to price gouge customers for vital drugs, force the agency to approve high-risk medical devices based on weak data, and encourage the overuse of antibiotics, creating more dangerous superbugs by paying hospitals to use new antibiotics even while most health experts are calling for less antibiotic use.Medical Device Concerns“21st CC guts already-weak FDA regulation of medical devices. The bill worsens problems by allowing companies to make changes to the highest-risk devices (like brain stents or artificial heart valves), after which an unlimited number of such changes could be made without even notifying the FDA,” Public Citizen notes. “Even simple changes can be dangerous, as illustrated by recent cases of catastrophic bone and tissue damage caused by changes to the material used in hip implants. Self-regulation for these types of changes would be disastrous.”Public Citizen also notes that the FDA would be forced to take articles published in medical journals at face value for the approval of new, high-risk medical devices, instead of reviewing the studies themselves for wrongdoing. The bill, according to Public Citizen, would force the FDA to approve devices even when the published study is based on outright fraud or misrepresentations without the agency being able to do its own review.Many medical devices are fast-tracked through the FDAโs 510(k) approval process, which allows devices deemed โsubstantially equivalentโ to existing medical devices to the market with little to no clinical testing.The agency has received criticism for expanding the definition of โsubstantially equivalentโ to products that advertise using new technologies and techniques, which are radically different from their predecessors.Many critics say that since the programโs inception in the 1980s, the term โsubstantially equivalentโ has become nearly meaningless.At the same time, concerns have emerged about problems with several devices implanted into the human body, such as metal-on-metal hip replacements and transvaginal surgical mesh, many of which were introduced under the โsubstantial equivalentโ test, with little pre-market testing to ensure they were safe. These same manufacturers engaged in marketing for their products that extolled the virtues of the devices, claiming that they involved โrevolutionaryโ designs and provide vast improvements over older devices.Originally designed for non-critical medical devices, such as band-aids and tongue suppressors, the โsubstantially equivalentโ program has expanded over the years to include numerous medical implants, including surgical mesh, artificial joint implants, defibrillators, stents and other critical devices that are permanently implanted into the human body.The program has come under increasing fire over the last several years, due to the number of recalls involving 510(k) approved devices, which were only found to carry unacceptable risks after they had already been implanted in thousands of patients. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Clinical Trials, CongressMore Lawsuit Stories Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator November 20, 2026 Roblox Lawsuit Claims Predator Groomed 11-Year-Old Boy, Causing PTSD, Depression and Anxiety November 20, 2026 Shiatsu Neck Massager Lawsuit Claims Device Caused Severe Burn Injuries November 20, 2026 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator (Posted: 2 days ago)An Abbott SCS lawsuit claims the company’s sales representatives performed unlicensed medical procedures, potentially delaying removal of a failed implant.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITConsolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (11/09/2026)Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026) Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: 3 days ago)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026) Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: 4 days ago)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator November 20, 2026
Roblox Lawsuit Claims Predator Groomed 11-Year-Old Boy, Causing PTSD, Depression and Anxiety November 20, 2026
Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator (Posted: 2 days ago)An Abbott SCS lawsuit claims the company’s sales representatives performed unlicensed medical procedures, potentially delaying removal of a failed implant.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITConsolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (11/09/2026)Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026)
Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: 3 days ago)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)
Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: 4 days ago)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)